Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-02-27 @ 10:34 AM
Study NCT ID:
NCT00985660
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2009-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg
Sponsor:
Mylan Pharmaceuticals Inc
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
NISO-0752
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Wayne Talton, Vice President, Regulatory Affairs
Old Organization:
Mylan Pharmaceuticals Inc.